Join
Live feed
·
INSIDERFilingvia Quantisnow
Corcept Therapeutics Incorporated logo

Chief Business Officer Robb Gary Charles was granted 998 shares and covered exercise/tax liability with 121 shares, increasing direct ownership by 1% to 79,503 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CORT (Corcept Therapeutics Incorporated) and more on Quantisnow.